Literature DB >> 26162785

The effect of low-dose dexmedetomidine on hemodynamics and anesthetic requirement during bis-spectral index-guided total intravenous anesthesia.

Hee Yeon Park1, Jong Yeop Kim2, Sang Hyun Cho2, Dongchul Lee1, Hyun Jeong Kwak3.   

Abstract

The purpose of this study was to evaluate the effects of low-dose dexmedetomidine on hemodynamics and anesthetic requirements during propofol and remifentanil anesthesia for laparoscopic cholecystectomy. Thirty adult patients were randomly allocated to receive dexmedetomidine infusion of 0.3 μg/kg/h (dexmedetomidine group, n = 15) or comparable volumes of saline infusion (control group, n = 15). Target controlled infusion of propofol and remifentanil was used for anesthetic induction and maintenance, and adjusted in order to maintain a bispectral index of 40-55 and hemodynamic stability. We measured hemodynamics and recorded total and mean infused dosages of propofol and remifentanil. For anesthesia induction and maintenance, mean infused doses of propofol (121 ± 27 vs. 144 ± 29 μg/kg/min, P = 0.04) and remifentanil (118 ± 27 vs. 150 ± 36 ng/kg/min, P = 0.01) were lower in the dexmedetomidine group than in the control group, respectively. The dexmedetomidine group required 16 % less propofol and 23 % less remifentanil. During anesthetic induction and maintenance, the dexmedetomidine group required fewer total doses of propofol (9.6 ± 2.3 vs. 12.4 ± 3.3 mg/kg, P = 0.01) and remifentanil (9.6 ± 3.4 vs. 12.7 ± 2.6 μg/kg, P = 0.01). The change in mean arterial pressure over time differed between the groups (P < 0.05). Significantly lower mean arterial pressure was observed in the dexmedetomidine group than in the control group at immediately and 5 min after pneumoperitoneum. The time to extubation after completion of drug administration did not differ between the groups (P = 0.25). This study demonstrated that a low-dose dexmedetomidine infusion of 0.3 μg/kg/h reduced propofol and remifentanil requirements as well as hemodynamic change by pneumoperitoneum without delayed recovery during propofol-remifentanil anesthesia for laparoscopic cholecystectomy.

Entities:  

Keywords:  Anesthetic requirement; Dexmedetomidine; Hemodynamics; Propofol; Remifentanil

Mesh:

Substances:

Year:  2015        PMID: 26162785     DOI: 10.1007/s10877-015-9735-2

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  26 in total

1.  Metabolic acidosis associated with propofol in the absence of other causative factors.

Authors:  Bethanie K Burow; Michael E Johnson; Douglas L Packer
Journal:  Anesthesiology       Date:  2004-07       Impact factor: 7.892

2.  Effect of dexmedetomidine on propofol requirements in healthy subjects.

Authors:  S Dutta; M D Karol; T Cohen; R M Jones; T Mant
Journal:  J Pharm Sci       Date:  2001-02       Impact factor: 3.534

3.  The influence of age on propofol pharmacodynamics.

Authors:  T W Schnider; C F Minto; S L Shafer; P L Gambus; C Andresen; D B Goodale; E J Youngs
Journal:  Anesthesiology       Date:  1999-06       Impact factor: 7.892

4.  Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.

Authors:  C F Minto; T W Schnider; T D Egan; E Youngs; H J Lemmens; P L Gambus; V Billard; J F Hoke; K H Moore; D J Hermann; K T Muir; J W Mandema; S L Shafer
Journal:  Anesthesiology       Date:  1997-01       Impact factor: 7.892

5.  Opioid consumption in total intravenous anesthesia is reduced with dexmedetomidine: a comparative study with remifentanil in gynecologic videolaparoscopic surgery.

Authors:  Neusa Maria H Bulow; Nilda Vargas Barbosa; Joao Batista Teixeira Rocha
Journal:  J Clin Anesth       Date:  2007-06       Impact factor: 9.452

6.  A balanced anesthesia with dexmedetomidine decreases postoperative nausea and vomiting after laparoscopic surgery.

Authors:  Islam M Massad; Wafa A Mohsen; Asma S Basha; Khaled R Al-Zaben; Mahmoud M Al-Mustafa; Subhi M Alghanem
Journal:  Saudi Med J       Date:  2009-12       Impact factor: 1.484

7.  Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators.

Authors:  Olivier Fourcade; Marie-Françoise Simon; Lawrence Litt; Kamran Samii; Hugues Chap
Journal:  Anesth Analg       Date:  2004-08       Impact factor: 5.108

8.  Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers.

Authors:  J B Dyck; M Maze; C Haack; D L Azarnoff; L Vuorilehto; S L Shafer
Journal:  Anesthesiology       Date:  1993-05       Impact factor: 7.892

9.  Recovery profiles from dexmedetomidine as a general anesthetic adjuvant in patients undergoing lower abdominal surgery.

Authors:  Norimasa Ohtani; Kotaro Kida; Kazuhiro Shoji; Yutaka Yasui; Eiji Masaki
Journal:  Anesth Analg       Date:  2008-12       Impact factor: 5.108

10.  The effect of dexmedetomidine on the adjuvant propofol requirement and intraoperative hemodynamics during remifentanil-based anesthesia.

Authors:  Woon-Seok Kang; Sung-Yun Kim; Jong-Chan Son; Ju-Deok Kim; Hasmizy Bin Muhammad; Seong-Hyop Kim; Tae-Gyoon Yoon; Tae-Yop Kim
Journal:  Korean J Anesthesiol       Date:  2012-02-20
View more
  9 in total

Review 1.  Journal of clinical monitoring and computing 2016 end of year summary: anesthesia.

Authors:  Jan F A Hendrickx; Andre M De Wolf
Journal:  J Clin Monit Comput       Date:  2017-01-07       Impact factor: 2.502

2.  Dexmedetomidine as an adjuvant during general anesthesia.

Authors:  Shinju Obara
Journal:  J Anesth       Date:  2018-05-15       Impact factor: 2.078

3.  Anesthetic Management of a Patient With Restless Legs Syndrome: A Case Report.

Authors:  Naohiro Ohshita; Koji Yamagata; Akio Himejima; Kazuhiro Kaneda; Teruyuki Yasutome; Yoshiko Matsuda; Yasuo M Tsutsumi; Yoshihiro Momota
Journal:  Anesth Prog       Date:  2020-12-01

4.  Comparison of the Effects of Dexmedetomidine on the Induction of Anaesthesia Using Marsh and Schnider Pharmacokinetic Models of Propofol Target-Controlled Infusion.

Authors:  Wan Mohd Nazaruddin Wan Hassan; Hai Siang Tan; Rhendra Hardy Mohamed Zaini
Journal:  Malays J Med Sci       Date:  2018-02-28

5.  Intraoperative dexmedetomidine attenuates postoperative systemic inflammatory response syndrome in patients who underwent percutaneous nephrolithotomy: a retrospective cohort study.

Authors:  Fang Tan; Xiaoliang Gan; Yingqing Deng; Xiaoyun Li; Na Guo; Ziqing Hei; Qianqian Zhu; Zhuang-Gui Chen; Shaoli Zhou
Journal:  Ther Clin Risk Manag       Date:  2018-02-14       Impact factor: 2.423

6.  Comparison of postoperative analgesic efficacy of low-dose bolus intravenous dexmedetomidine and intraperitoneal dexmedetomidine with bupivacaine in patients undergoing laparoscopic cholecystectomy: A randomised, controlled trial.

Authors:  Geetanjali Tolia Chilkoti; Manish Kumar; Medha Mohta; Ashok Kumar Saxena; Naveen Sharma; Jitender Singh
Journal:  Indian J Anaesth       Date:  2019-02

7.  Effect of dexmedetomidine on opioid consumption and pain control after laparoscopic cholecystectomy: a meta-analysis of randomized controlled trials.

Authors:  Yang Liu; Guomin Zhao; Xuefeng Zang; Feiping Lu; Ping Liu; Wei Chen
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-03-08       Impact factor: 1.195

8.  Preoperative dexmedetomidine and intraoperative bradycardia in laparoscopic cholecystectomy: a meta-analysis with trial sequential analysis.

Authors:  Alessandro De Cassai; Nicolò Sella; Federico Geraldini; Francesco Zarantonello; Tommaso Pettenuzzo; Laura Pasin; Margherita Iuzzolino; Nicolò Rossini; Elisa Pesenti; Giovanni Zecchino; Marina Munari; Paolo Navalesi; Annalisa Boscolo
Journal:  Korean J Anesthesiol       Date:  2022-01-12

9.  Evaluation of postoperative analgesic efficacy and perioperative hemodynamic changes with low dose intravenous dexmedetomidine infusion in patients undergoing laparoscopic cholecystectomy - A randomised, double-blinded, placebo-controlled trial.

Authors:  Geetanjali T Chilkoti; Ganeshan Karthik; Rajesh Rautela
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2020-02-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.